Halozyme Therapeutics

Filed a patent for "injection device" on Thu, December 22, 2022

Filed a patent for "button actuated auto-injector" on Thu, December 22, 2022

Filed a patent for "hyaluronidase enzyme formulations for high volume administration" on Wed, February 15, 2023

Filed a patent for "hyaluronidase enzyme formulations for high volume administration" on Fri, June 9, 2023

Filed a patent for "compositions of adenosine deaminase-2 (ada2), variants thereof and methods of using same" on Thu, June 29, 2023

Filed a patent for "ph20 polypeptide variants, formulations and uses thereof" on Thu, September 21, 2023

Filed a patent for "ph20 polypeptide variants, formulations and uses thereof" on Thu, May 18, 2023

Filed a patent for "ph20 polypeptide variants, formulations and uses thereof" on Thu, July 6, 2023

Filed a patent for "ph20 polypeptide variants, formulations and uses thereof" on Thu, August 10, 2023

Filed a patent for "ph20 polypeptide variants, formulations and uses thereof" on Thu, November 9, 2023

Filed a patent for "ph20 polypeptide variants, formulations and uses thereof" on Thu, September 21, 2023

Filed a patent for "ph20 polypeptide variants, formulations and uses thereof" on Thu, September 14, 2023

Filed a patent for "dosing regimen" on Thu, December 21, 2023

Filed a patent for "ph20 polypeptide variants, formulations and uses thereof" on Thu, January 11, 2024

Filed a patent for "soluble hyaluronidase glycoprotein (shasegp), process for preparing the same, uses and pharmaceutical compositions comprising thereof" on Thu, October 12, 2023

Filed a patent for "ph20 polypeptide variants with a modification at position 309 of the ph20 polypeptide and a method of making thereof" on Thu, January 25, 2024

Filed a patent for "ph20 polypeptide variants, formulations and uses thereof" on Thu, January 25, 2024

Filed a patent for "ph20 polypeptide variants, formulations and uses thereof" on Thu, January 4, 2024

Filed a patent for "ph20 polypeptide variants, formulations and uses thereof" on Thu, January 4, 2024

Filed a patent for "combination therapy with a hyaluronan-degrading enzyme and an immune checkpoint inhibitor" on Thu, November 24, 2022